Innovating.works Conecta tu I+D

Showing 1 to 20 of 93 results

e-QuoL: e health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patien... UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUNIVERSITAET MAINZ participó en un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 Cancer affects 35,000 children, adolescents and young adults (CAYAC) in Europe each year. Current 5-year survival rates are 80%, but the int...
2023-12-13 - 2027-12-31 | Financiado

LIVERAIM: A Biomarker Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Thera... UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUNIVERSITAET MAINZ participó en un HORIZON EUROPE: HORIZON-JU-IHI-2022-03-single-stage Liver cirrhosis and liver cancer are common and responsible for high morbidity, impaired quality of life, major costs for healthcare systems...
2023-11-27 - 2030-02-28 | Financiado

IMDIGICOMM: Imagine if Platforms. European Progressive Parties and the Digital Commons. Mapping Ideologies and... UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUNIVERSITAET MAINZ participó en un HORIZON EUROPE: HORIZON-MSCA-2022-PF-01 Putting the ‘people at the centre of the digital transformation’ is one of the core goals of EU strategies for the digital decade. However,...
2023-04-20 - 2026-05-31 | Financiado

ONCOSCREEN: A European shield against colorectal cancer based on novel, more precise and affordable risk-based s... UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUNIVERSITAET MAINZ participó en un HORIZON EUROPE: HORIZON-MISS-2021-CANCER-02 With Colorectal Cancer (CRC) being accountable for 12.4% of all deaths due to cancer, and with only 14% of EU citizens participating in scre...
2022-11-28 - 2026-12-31 | Financiado

CITRUS: Closed-loop Individualized image-guided Transcranial Ultrasonic Stimulation UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUNIVERSITAET MAINZ participó en un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01 We are joining forces across Europe to advance a new non-invasive technology – transcranial ultrasound stimulation (TUS) – to reversibly mod...
2022-09-14 - 2026-09-30 | Financiado

RELEVIUM: Improving quality of life of advanced pancreatic cancer patients through an AI-guided multimodal int... UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUNIVERSITAET MAINZ tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 Pancreatic cancer has the lowest survival rate amongst other cancers and is responsible for 95,000 deaths every year in the EU. Its treatmen...
2022-09-01 - 2026-08-31 | Financiado

ENCRYPT: A SCALABLE AND PRACTICAL PRIVACY-PRESERVING FRAMEWORK UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUNIVERSITAET MAINZ participó en un HORIZON EUROPE: HORIZON-CL3-2021-CS-01 The deluge of big data, accompanied by developments in software and hardware technologies leveraging them, has created new opportunities for...
2022-06-22 - 2025-06-30 | Financiado

NextGEM: Next Generation Integrated Sensing and Analytical System for Monitoring and Assessing Radiofrequency... UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUNIVERSITAET MAINZ participó en un HORIZON EUROPE: HORIZON-HLTH-2021-ENVHLTH-02 The NextGEM vision is to assure safety for EU citizens when employing existing and future EMF based telecommunication technologies. This wil...
2022-05-20 - 2026-06-30 | Financiado

FORTEe: Get strong to fight childhood cancer an exercise intervention for children and adolescents undergoi... UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUNIVERSITAET MAINZ tramitó un H2020: H2020-SC1-BHC-2018-2020 Cancer is the first leading cause of death by non-communicable diseases in children in Europe. During cancer treatment, patients’ morbidity...
2021-02-03 - 2026-08-31 | Financiado

SLEEP REVOLUTION: Revolution of sleep diagnostics and personalized health care based on digital diagnostics and therap... UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUNIVERSITAET MAINZ participó en un H2020: H2020-SC1-BHC-2018-2020 Obstructive sleep apnea (OSA) is associated with various negative health consequences including increased risk of heart disease, hypertensio...
2021-02-01 - 2025-02-28 | Financiado

PanCareSurPass: PanCare studies of the scale up and implementation of the digital Survivorship Passport to improve p... UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUNIVERSITAET MAINZ tramitó un H2020: H2020-SC1-BHC-2018-2020 Almost 500,000 former childhood cancer patients (CCS) are now living in Europe. Compared to the general population, CCS represent a vulnerab...
2021-01-21 - 2025-02-28 | Financiado

MolDynForSyn: How dendritic mRNA and protein distributions shape synaptic plasticity UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUNIVERSITAET MAINZ participó en un H2020: ERC-2020-STG Proteins are the building blocks of life and neurons constantly need proteins to remain functional. This is a formidable challenge because n...
2020-10-29 - 2026-09-30 | Financiado

LiverScreen: Screening for liver fibrosis population based study across European countries UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUNIVERSITAET MAINZ participó en un H2020: H2020-SC1-BHC-2018-2020 Liver cirrhosis is a very common and severe chronic disease, responsible for high morbidity, impaired quality of life, major healthcare cost...
2019-12-12 - 2025-06-30 | Financiado

ONCORELIEF: A digital guardian angel enhancing cancer patient s wellbeing and health status improvement followin... UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUNIVERSITAET MAINZ participó en un H2020: H2020-SC1-DTH-2018-2020 The burden of cancer is rising globally and is estimated to have reached 18.1 million new cases and 9.6 million cancer deaths in 2018. Desp...
2019-11-05 - 2023-06-30 | Financiado

BD4QoL: Big Data Models and Intelligent tools for Quality of Life monitoring and participatory empowerment o... UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUNIVERSITAET MAINZ participó en un H2020: H2020-SC1-DTH-2018-2020 Head and neck cancer can take away a patient’s right to feel human, and its impact on physical appearance, physical functioning, psychologic...
2019-11-05 - 2024-12-31 | Financiado

SUPRAVACC: Supramolecular engineering of glycan decorated peptides as synthetic vaccines UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUNIVERSITAET MAINZ participó en un H2020: ERC-2018-COG The main and most important feature of vaccines is the induction of an immunological memory response, which is key to providing long-term pr...
2019-03-20 - 2025-03-31 | Financiado

IM2PACT: Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics IM2PACT Into The B... UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUNIVERSITAET MAINZ participó en un H2020: H2020-JTI-IMI2-2017-12-two-stage The overall aim is to further the understanding of the BBB in health and disease states towards the development of innovative brain delivery...
2018-12-14 - 2024-12-31 | Financiado

TICARDIO: Thrombo inflammation in cardiovascular disease UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERGUNIVERSITAET MAINZ tramitó un H2020: H2020-MSCA-ITN-2018 The demographic change with aging populations places a heavy burden on health care systems worldwide. Despite all medical advances, age rema...
2018-08-20 - 2023-11-30 | Financiado

UMC-Mainz